A
COLL icon

AlphaQuest’s Collegium Pharmaceutical COLL Stock Holding History

AlphaQuest’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-31,967
Closed -$1.48M – 453
2025
Q4 		$1.48M Buy
31,967
+6,964
+28% +$291K 0.08% 283
2025
Q3 		$875K Buy
25,003
+15,769
+171% +$548K 0.06% 491
2025
Q2 		$273K Buy
9,234
+2,516
+37% +$71.8K 0.03% 944
2025
Q1 		$201K Sell
6,718
-6,062
-47% -$185K 0.02% 995
2024
Q4 		$366K Buy
12,780
+374
+3% +$12.4K 0.05% 613
2024
Q3 		$479K Sell
12,406
-6,421
-34% -$229K 0.04% 673
2024
Q2 		$606K Buy
18,827
+12,244
+186% +$425K 0.08% 394
2024
Q1 		$256K Buy
+6,583
New +$230K 0.04% 574

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

AlphaQuest's COLL Position: Q1 2026 in Review

AlphaQuest sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 31,967 shares — an estimated $1.48M sold.

AlphaQuest first reported a position in COLL in Q1 2024 and held it in 8 quarters. The position peaked at $1.48M in Q4 2025. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • AlphaQuest reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 31,967 Collegium Pharmaceutical shares in Q1 2026, an estimated $1.48M.
  • AlphaQuest first reported a position in Collegium Pharmaceutical in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's Collegium Pharmaceutical position peaked at $1.48M in Q4 2025.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.